This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Sep;85(5):315-6.

doi: 10.1136/sti.2008.034793.

HPV vaccine strategies: the cost of HPV and the choice of vaccine

Sheldon R Morris

PMID: 19773455
DOI: 10.1136/sti.2008.034793

Editorial

HPV vaccine strategies: the cost of HPV and the choice of vaccine

Sheldon R Morris. Sex Transm Infect. 2009 Sep.

. 2009 Sep;85(5):315-6.

doi: 10.1136/sti.2008.034793.

Author

Sheldon R Morris

PMID: 19773455
DOI: 10.1136/sti.2008.034793

No abstract available

PubMed Disclaimer

Comment on

Determining the cost of genital warts: a study from Ireland.
Dee A, Howell F, O'Connor C, Cremin S, Hunter K. Dee A, et al. Sex Transm Infect. 2009 Sep;85(5):402-3. doi: 10.1136/sti.2008.033837. Epub 2008 Nov 12. Sex Transm Infect. 2009. PMID: 19004863

Similar articles

(Not) warts and all.
Hammond P. Hammond P. BMJ. 2008 Oct 23;337:a2186. doi: 10.1136/bmj.a2186. BMJ. 2008. PMID: 18948345 No abstract available.
Comparing bivalent and quadrivalent HPV vaccines.
Verheijen RH. Verheijen RH. BMJ. 2011 Sep 27;343:d5720. doi: 10.1136/bmj.d5720. BMJ. 2011. PMID: 21951757 No abstract available.
A brief history of economic evaluation for human papillomavirus vaccination policy.
Beutels P, Jit M. Beutels P, et al. Sex Health. 2010 Sep;7(3):352-8. doi: 10.1071/SH10018. Sex Health. 2010. PMID: 20719227
Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
McCormack PL, Joura EA. McCormack PL, et al. BioDrugs. 2011 Oct 1;25(5):339-43. doi: 10.2165/11205060-000000000-00000. BioDrugs. 2011. PMID: 21942919 Review.
Using the new HPV vaccines in clinical practice.
Widdice LE, Kahn JA. Widdice LE, et al. Cleve Clin J Med. 2006 Oct;73(10):929-35. doi: 10.3949/ccjm.73.10.929. Cleve Clin J Med. 2006. PMID: 17044318 Review.

See all similar articles

Cited by

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
Westra TA, Stirbu-Wagner I, Dorsman S, Tutuhatunewa ED, de Vrij EL, Nijman HW, Daemen T, Wilschut JC, Postma MJ. Westra TA, et al. BMC Infect Dis. 2013 Feb 7;13:75. doi: 10.1186/1471-2334-13-75. BMC Infect Dis. 2013. PMID: 23390964 Free PMC article.
Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model.
Jit M, Chapman R, Hughes O, Choi YH. Jit M, et al. BMJ. 2011 Sep 27;343:d5775. doi: 10.1136/bmj.d5775. BMJ. 2011. PMID: 21951758 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire